Plandai Biotech Stock Price History
If you're considering investing in Plandai Pink Sheet, it is important to understand the factors that can impact its price. Plandai Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.26, which implies the firm had a 0.26 % return per unit of risk over the last 3 months. We were able to interpolate data for zero different technical indicators, which can help you to evaluate if expected returns of 73.33% are justified by taking the suggested risk.
Plandai Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Plandai |
Sharpe Ratio = 0.2588
Best Portfolio | Best Equity | PLPL | ||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
283.36 actual daily | 96 96% of assets are less volatile |
Expected Return
4.96 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
0.26 actual daily | 20 80% of assets perform better |
Based on monthly moving average Plandai Biotech is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Plandai Biotech by adding it to a well-diversified portfolio.
Plandai Biotech Pink Sheet Price History Chart
There are several ways to analyze Plandai Stock price data. The simplest method is using a basic Plandai candlestick price chart, which shows Plandai Biotech price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | December 26, 2024 | 1.0E-4 |
Lowest Price | January 3, 2025 | 0.0 |
Plandai Pink Sheet Price History Data
The price series of Plandai Biotech for the period between Fri, Dec 27, 2024 and Thu, Mar 27, 2025 has a statistical range of 0.0 with a coefficient of variation of 31.87. The price distribution for the period has arithmetic mean of 0.0. The median price for the last 90 days is 0.0. The company completed stock split (1:2000) on 19th of September 2008.Open | High | Low | Close | Volume | ||
03/26/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 5,000 | |
03/25/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/24/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/21/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/20/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/19/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/18/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 100,000 | |
03/17/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 10,000 | |
03/14/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/13/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/12/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/11/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 200,001 | |
03/10/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 6,000,000 | |
03/07/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/06/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/05/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/04/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/03/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,700,000 | |
02/28/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 8,965,999 | |
02/27/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/26/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 2,057,500 | |
02/25/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,625,120 | |
02/24/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 200,000 | |
02/21/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/20/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 10,000 | |
02/19/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/18/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 170,001 | |
02/14/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 2,430,500 | |
02/13/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/12/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/11/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/10/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 2,501,515 | |
02/07/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 500,000 | |
02/06/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 30,000 | |
02/05/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/04/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 3,000,000 | |
02/03/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 5,100,000 | |
01/31/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 5,300,000 | |
01/30/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 2,450,750 | |
01/29/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 3,892,601 | |
01/28/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/27/2025 | 0.0001 | 0.0002 | 0.0001 | 0.0001 | 27,350,000 | |
01/24/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 5,000 | |
01/23/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 3,000,000 | |
01/22/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,883,208 | |
01/21/2025 | 0.0001 | 0.0002 | 0.0001 | 0.0001 | 11,670,832 | |
01/17/2025 | 0.0001 | 0.0002 | 0.0001 | 0.0001 | 18,064,100 | |
01/16/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/15/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 5,768,849 | |
01/14/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,009,000 | |
01/13/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 7,390,000 | |
01/10/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 174.00 | |
01/08/2025 | 0.0002 | 0.0002 | 0.0001 | 0.0001 | 23,288,999 | |
01/07/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 20,468,826 | |
01/06/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 5,969,998 | |
01/03/2025 | 0.00 | 0.00 | 0.00 | 0.00 | 36,475,500 | |
01/02/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/31/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/30/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 2,805,200 | |
12/27/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/26/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 52,506,358 |
About Plandai Biotech Pink Sheet history
Plandai Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Plandai is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Plandai Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Plandai Biotech stock prices may prove useful in developing a viable investing in Plandai Biotech
Planda Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. Planda Biotechnology, Inc. is based in London, the United Kingdom. Diamond Ranch is traded on OTC Exchange in the United States.
Plandai Biotech Pink Sheet Technical Analysis
Plandai Biotech technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
All Next | Launch Module |
Other Information on Investing in Plandai Pink Sheet
Plandai Biotech financial ratios help investors to determine whether Plandai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Plandai with respect to the benefits of owning Plandai Biotech security.